RecruitingPhase 1NCT06771479

A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine

Studying Human infection by orthopoxvirus

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Institute Of Biological Products
Principal Investigator
Shuang Li, Master
Henan Infectious Disease Hospital
Intervention
MVA strain monkeypox attenuated live vaccine (low dose)(biological)
Enrollment
120 enrolled
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06771479 on ClinicalTrials.gov

Other trials for Human infection by orthopoxvirus

Additional recruiting or active studies for the same condition.

See all trials for Human infection by orthopoxvirus

← Back to all trials